Bone Health Technologies Awarded New Patent for Wearable Treatment for Osteopenia and Osteoporosis in Post-Menopausal Women
Bone Health Technologies (BHT) has been granted its fourth patent to further its commercialization of the Osteoboost device.
Bone Health Technologies (BHT) has been granted its fourth patent to further its commercialization of the Osteoboost device.
Osteoboost Reduced the Loss of Vertebral Bone Strength by 83% in One Year for Per Protocol Participants Vancouver, BC, Canada (October 13, 2023)– Bone Health Technologies (BHT), a leading innovator in health technologies to improve bone health, is presenting top-line results from its pivotal trial for the Osteoboost at ASBMR…
Read more
Redwood City, CA (SEPTEMBER 20TH, 2023) – Bone Health Technologies (BHT), a leader in developing technologies for improving bone health and preventing bone diseases, announces the appointment of two new board directors: Jeani Delagardelle and Eric Meyer. Onboarding these two expert thought leaders will aid in progressing BHT’s development, research,…
Read more
Per Protocol Participants saw an 85% Reduction in the Loss of Vertebral Bone Density in One Year Chicago, IL (June 16, 2023)– Bone Health Technologies (BHT), a pioneer in health technologies for preventing and treating bone health diseases, is presenting pivotal trial data for Osteoboost, a novel treatment for low…
Read more
SAN FRANCISCO, CA (May 3, 2023) – Bone Health Technologies (BHT), a leading innovator of technologies for improving bone health and preventing bone diseases, names Dr. Pamela Peeke as the new Chief Medical Officer and board member and appoints two new board members: Dr. Kian Beyzavi and Marcie Hamilton. The…
Read more